Study_9.1_CalCurves

Study_9.1_CalCurves
Clustergrammer Heatmap
 
Download
ABSciex4000_Study9-1_Site19_Blinded & Blanks only_2013-09-22_19-22-11.zip2015-02-06 14:33:5734125250750489.1_19_Blinded
ABSciex4000_Study9-1_Site19_CalCurves only_2013-09-22_12-52-27.zip2015-02-06 15:03:1434125250750449.1_19_CalCurves
site32_study9.1_rep2-4_Blinded_2013-09-22_19-10-46.zip2015-02-06 14:33:5734125250750569.1_32_Blinded
site32_study9.1_rep2-4_AtoQC_4_2013-09-21_19-43-47.zip2015-02-06 15:03:1434125250750549.1_32_CalCurves
Site52_5500_Blindedsamples_2013-09-22_19-11-26.zip2015-02-06 14:33:5734125250750519.1_52_Blinded
Site52_5500_Curves_2013-09-23_15-59-10.zip2015-02-06 15:03:1434125250750449.1_52_CalCurves
Site54_Study9-1_blindedsamples_LH_083011_v1_2013-09-22_19-12-07.zip2015-02-06 14:33:5734125250750529.1_54_Blinded
Site54_Study9-1_standardcurves_083011_v1_2013-09-21_20-30-30.zip2015-02-06 15:03:1434125250750449.1_54_CalCurves
Study9p1_site_56A_5500_Blinded_20120425_Final_2013-09-22_19-12-41.zip2015-02-06 14:33:5734125250750249.1_56A_Blinded
Study9p1_site_56A_5500_20120425_Final_2013-09-21_20-30-56.zip2015-02-06 15:03:1434125250750489.1_56A_CalCurves
Study9-1_Site56B_Agilent6490_042612_Blinded_only_2013-09-22_13-27-58.zip2015-02-06 14:33:5734125250750499.1_56B_Blinded
Study9-1_Site56B_Agilent6490_042612_CalCurves_only_2013-09-22_13-28-46.zip2015-02-06 15:03:1434125250750449.1_56B_CalCurves
Study9_1_Site56C_Final_BLINDED_Annotated_110111_2013-09-22_19-14-32.zip2015-02-06 14:33:5734125250752489.1_56C_Blinded
Study9_1_Site56C_Final_CURVE_Annotated_110111_2013-09-22_09-29-34.zip2015-02-06 15:03:1434125250752449.1_56C_CalCurves
Site 65 Study9.1 All Blinded Samples_2013-09-22_19-15-56.zip2015-02-06 14:33:5734125250750249.1_65_Blinded
Site 65 Study9.1 All Curves_2013-09-22_09-29-51.zip2015-02-06 15:03:1434125250750449.1_65_CalCurves
Study9_1_Site73_Xevo_blinded_v01_2013-09-22_19-18-56.zip2015-02-06 14:33:5734125250752249.1_73A_Blinded
Study9_1_Site73_Xevo_allcurves_v01_2013-09-22_09-31-31.zip2015-02-06 15:03:1434125250752449.1_73A_CalCurves
Study9_Site73_blinded_01_2013-09-22_19-18-04.zip2015-02-06 14:33:5734125250750249.1_73_Blinded
Study9_Site73_curve_01_2013-09-22_09-30-12.zip2015-02-06 15:03:1434125250750449.1_73_CalCurves
9-1_Site86a_Blinded_2013-09-22_19-20-25.zip2015-02-06 14:33:5734124248746489.1_86A_Blinded
9-1_Site86a_CalCurve_2013-09-22_09-32-28.zip2015-02-06 15:03:1434124248746439.1_86A_CalCurves
Site86_Study9.1_all_blinded_with_blanks_(annotations_lost)_2013-09-22_13-14-52.zip2015-02-06 14:33:5734125250750689.1_86_Blinded
Site86_Study9.1_all_curves_with_blanks_(annotations_lost)_2013-09-22_13-14-11.zip2015-02-06 15:03:1434125250750769.1_86_CalCurves
CPTACstudy9_Agilent_LH_BlindedRuns_2013-09-22_19-21-32.zip2015-02-06 14:33:5734125250750529.1_90_Blinded
CPTACstudy9_Agilent_LH_CalCurve_A1-J1_A4-J4_2013-09-22_09-39-30.zip2015-02-06 15:03:1434123246738449.1_90_CalCurves
Study9-2_site32_Blinded_2013-09-24_10-37-26.zip2015-02-06 15:34:11341253651,095579.2_32_Blinded
Study9-2_site32_Calcurve_2013-09-23_15-53-23.zip2015-02-06 16:11:47341253651,095449.2_32_CalCurves
Site52_Study9-2_BlindedSamples_20121214_2013-09-24_10-39-36.zip2015-02-06 15:34:11341253651,095249.2_52_Blinded
Site52_Study9-2_CalCurve_20121214_2013-09-23_15-43-39.zip2015-02-06 16:11:47341253651,095449.2_52_CalCurves
Site54_Study9-2_BlindedSamples_20120411_2013-09-24_10-40-12.zip2015-02-06 15:34:11341253651,095509.2_54_Blinded
Site54_Study9-2_CalCurve_20120411_2013-09-23_16-05-34.zip2015-02-06 16:11:47341253651,095449.2_54_CalCurves
ABSciex_5500_Study9-2_Site56A_0622012_v2_Blinded_only_2013-09-24_10-48-51.zip2015-02-06 15:34:11341253651,095469.2_56A_Blinded_postDesalt
preDS_Study9-2_Site56A_030813_v1_Blinded_only_2013-09-24_10-56-37.zip2015-02-06 15:34:12341253651,095529.2_56A_Blinded_preDesalt
ABSciex_5500_Study9-2_Site56A_0622012_v2_CalCurve_only2_2013-09-24_10-51-38.zip2015-02-06 16:11:47341253651,095469.2_56A_CalCurves_postDesalt
preDS_Study9-2_Site56A_030813_v1_CalCurve_only_2013-09-24_10-53-47.zip2015-02-06 16:11:47341253651,095429.2_56A_CalCurves_preDesalt
Study9-2_Site56B_postds_050112_FINAL_v2_Blinded_Only_2013-09-24_11-06-35.zip2015-02-06 15:34:12341253651,095419.2_56B_Blinded_postDesalt
Study9-2_preds_Site56B_022013_FINAL_Blinded_only_2013-09-24_11-14-37.zip2015-02-06 15:34:12341253651,095519.2_56B_Blinded_preDesalt
Study9-2_Site56B_postds_050112_FINAL_v2_CalCurves_Only_2013-09-24_11-00-21.zip2015-02-06 16:11:47341253651,095459.2_56B_CalCurves_postDesalt
Study9-2_preds_Site56B_022013_FINAL_CalCurves_only_2013-09-24_11-13-09.zip2015-02-06 16:11:47341253651,095439.2_56B_CalCurves_preDesalt
Study9_2_Site56C_LH15N_CurveFinal_Annotated_PlusBlanks_021113_Blinded_only_2013-09-24_11-20-55.zip2015-02-06 15:34:12341253651,098499.2_56C_Blinded
Study9_2_Site56C_LH15N_CurveFinal_Annotated_PlusBlanks_021113_CalCurves_only_2013-09-24_11-20-01.zip2015-02-06 16:11:47341253651,098449.2_56C_CalCurves
Site 65 Study9.2 Blinded 051612_2013-09-24_11-23-02.zip2015-02-06 15:34:12341253651,095249.2_65_Blinded_postDesalt
Site 65 Study9.2 Pre Blinded Final_2013-09-24_11-23-33.zip2015-02-06 15:34:12341253651,095249.2_65_Blinded_preDesalt
Site 65 Study9.2 All Curves 051612_2013-09-24_11-20-20.zip2015-02-06 16:11:47341253651,095449.2_65_CalCurves_postDesalt
Site 65 Study9.2 PRE Curves Final_2013-09-24_11-24-16.zip2015-02-06 16:11:47341253651,095449.2_65_CalCurves_preDesalt
Study9_2_Site73a_blinded_v01_2013-09-24_11-38-29.zip2015-02-06 15:34:12341253651,098249.2_73A_Blinded
Study9_2_Site73a_CalCurve_v01_2013-09-24_11-27-27.zip2015-02-06 16:11:47341253651,098449.2_73A_CalCurves
CPTAC_Study9_2_site73_blinded_v02_2013-09-24_11-37-57.zip2015-02-06 15:34:12341253651,095349.2_73_Blinded
CPTAC_Study9_2_site73_curves_v01_2013-09-24_11-26-06.zip2015-02-06 16:11:47341253651,095449.2_73_CalCurves
9-2_Site86a_Blinded_2013-09-24_11-40-58.zip2015-02-06 15:34:12341253651,098489.2_86A_Blinded
9-2_Site86a_CalCurve_2013-09-24_11-29-44.zip2015-02-06 16:11:47341253651,098409.2_86A_CalCurves
9-2_Site86_Blinded_2013-09-24_11-39-08.zip2015-02-06 15:34:12341253651,095489.2_86_Blinded
9-2_Site86_CalCurve_2013-09-24_11-28-53.zip2015-02-06 16:11:47341253651,095409.2_86_CalCurves
Mouse_HeavyGradient_C2C12matrix_2020-04-02_09-09-41.sky.zip2020-04-02 10:23:41357114252612Analysis of Linearity of Heavy Peptides
6Erbb2_3KRT19_iRT_20131120_cal_curve_20-2_2015-06-02_15-26-27.sky.zip2015-06-16 16:06:201219288814calibration curve for extraction reproducibility (replicate 2)
6Erbb2_3KRT19_iRT_20131120_cal_curve_20-3_2015-06-02_15-35-28.sky.zip2015-06-16 16:06:331219288814calibration curve for extraction reproducibility (replicate 3)
6Erbb2_3KRT19_iRT_20131120_cal01_2015-06-02_13-42-34.sky.zip2015-06-16 16:06:061219288814calibration curve for HER2 quantification in entire cohort (replicate 1)
6Erbb2_3KRT19_iRT_20131120_cal02_2015-06-02_13-51-16.sky.zip2015-06-16 16:06:061219288814calibration curve for HER2 quantification in entire cohort (replicate 2)
6Erbb2_3KRT19_iRT_20131120_cal03_2015-06-02_13-55-19.sky.zip2015-06-16 16:06:061219288814calibration curve for HER2 quantification in entire cohort (replicate 3)
Assay_PeptideSelection_2020-02-26_14-52-16.sky.zip2020-03-04 14:52:556985,8707,17042,2392Discovery Data for Peptide Selection
6Erbb2_3KRT19_iRT_20131120_samples_20-2_2015-06-02_15-28-52.sky.zip2015-06-16 16:06:201219288827extraction reproducibility in a subset of 9 samples (extraction replicate 2)
6Erbb2_3KRT19_iRT_20131120_samples_20-3_2015-06-02_15-38-21.sky.zip2015-06-16 16:06:331219288827extraction reproducibility in a subset of 9 samples (extraction replicate 3)
6Erbb2_3KRT19_iRT_20131120_samples1_2015-06-02_14-25-11.sky.zip2015-06-16 16:05:271219288840HER2 quantification data in entire cohort (injection replicate 1)
6Erbb2_3KRT19_iRT_20131120_samples2_2015-06-02_14-37-13.sky.zip2015-06-16 16:05:271219288840HER2 quantification data in entire cohort (injection replicate 2)
6Erbb2_3KRT19_iRT_20131120_samples3_2015-06-02_14-41-56.sky.zip2015-06-16 16:05:271219288840HER2 quantification data in entire cohort (injection replicate 3)
20May2018_NewPrep_BlastsRhoTubes_2020-02-28_09-40-02.sky.zip2020-03-04 14:52:55346914045936In Vitro C2C12 experiment
Mouse_StatinExperiment_2_2020-02-28_09-38-48.sky.zip2020-03-04 14:52:56347214143322In Vitro Statin Treatment of C2C12 Cells
Analysis_04152019_Tissues_2020-02-28_09-36-44.sky.zip2020-03-04 14:52:56386713146732In Vivo Analysis of Mouse Tissue
Tissue_10dinj_2020-02-28_09-44-33.sky.zip2020-03-04 14:52:5633469233963In Vivo Statin Treatment Experiment
Tubulin_Ova_AspN_SIS_Results_20200203_NoiRT_Linearity_Processed_Cell culture.sky.zip2020-04-17 07:12:074253018436Linearity and reproducibility in cell culture and Trichostatin A treatment of cells
Tubulin_Ova_AspN_SIS_Results_20200203_NoiRT_Linearity_Processed_Spinal cord_Brain homogenate.sky.zip2020-04-17 07:12:074253018019Linearity in brain homegenate and spinal cord along with unknown spinal cord estimation
Erbb2_6_peptides_iRT_Pyro_linearity_2015-06-09_12-54-57.sky.zip2015-06-16 16:06:471217236942linearity in P. furiosus background
Erbb2_6_peptides_iRT_TN_linearity_2015-06-09_13-02-57.sky.zip2015-06-16 16:06:471217236942linearity in TNBC background
Erbb2_6_peptides_iRT_Pyro_LOQ_2015-06-09_12-50-05.sky.zip2015-06-16 16:07:061217236918lower limit of quantification data
MitoPreps_C2C12_Soleus_2020-02-28_09-44-19.sky.zip2020-03-04 14:52:56346913540835Mito Enrichments for Method Development
20170210_HCy_MRM_AKCMFCS_analysis01_2019-09-12_14-50-27.sky.zip2019-09-14 16:21:412482823469Primary human keratinocyte conditioned media containing FCS_0 pg/mL - 1000 pg/mL cytokines spiked-in_No fractionation_MRM runs
20170201_HCy_MRM_AKCMFCS_analysis01_lvl1000_2019-09-12_14-41-51.sky.zip2019-09-14 16:21:4124828235410Primary human keratinocyte conditioned media containing FCS_1000 pg/mL cytokines spiked-in_High pH reversed-phase peptide fractionation_MRM runs
20170201_HCy_MRM_AKCMFCS_analysis01_lvl125_2019-09-12_14-39-48.sky.zip2019-09-14 16:21:4024828235410Primary human keratinocyte conditioned media containing FCS_125 pg/mL cytokines spiked-in_High pH reversed-phase peptide fractionation_MRM runs
20170201_HCy_MRM_AKCMFCS_analysis01_lvl250_2019-09-12_14-40-35.sky.zip2019-09-14 16:21:4124828235410Primary human keratinocyte conditioned media containing FCS_250 pg/mL cytokines spiked-in_High pH reversed-phase peptide fractionation_MRM runs
20170201_HCy_MRM_AKCMFCS_analysis01_lvl37-5_2019-09-12_14-38-01.sky.zip2019-09-14 16:21:4024828235410Primary human keratinocyte conditioned media containing FCS_37.5 pg/mL cytokines spiked-in_High pH reversed-phase peptide fractionation_MRM runs
20170201_HCy_MRM_AKCMFCS_analysis01_lvl500_2019-09-12_14-41-14.sky.zip2019-09-14 16:21:4124828235410Primary human keratinocyte conditioned media containing FCS_500 pg/mL cytokines spiked-in_High pH reversed-phase peptide fractionation_MRM runs
20170324_HCy_MRM_AKCMFCS_analysis01_lvl500_Repl1_2019-09-12_14-50-52.sky.zip2019-09-14 16:21:4124828234710Primary human keratinocyte conditioned media containing FCS_500 pg/mL cytokines spiked-in_High pH reversed-phase peptide fractionation_Reproducibility experiment_Day 1_Replicate 1_MRM runs
20170324_HCy_MRM_AKCMFCS_analysis01_lvl500_Repl2_2019-09-12_14-51-17.sky.zip2019-09-14 16:21:4224828234710Primary human keratinocyte conditioned media containing FCS_500 pg/mL cytokines spiked-in_High pH reversed-phase peptide fractionation_Reproducibility experiment_Day 1_Replicate 2_MRM runs
20170324_HCy_MRM_AKCMFCS_analysis01_lvl500_Repl3_2019-09-12_14-51-46.sky.zip2019-09-14 16:21:4224828234710Primary human keratinocyte conditioned media containing FCS_500 pg/mL cytokines spiked-in_High pH reversed-phase peptide fractionation_Reproducibility experiment_Day 1_Replicate 3_MRM runs
20170324_HCy_MRM_AKCMFCS_analysis01_lvl500_Repl4_2019-09-12_14-52-12.sky.zip2019-09-14 16:21:4224828234710Primary human keratinocyte conditioned media containing FCS_500 pg/mL cytokines spiked-in_High pH reversed-phase peptide fractionation_Reproducibility experiment_Day 1_Replicate 4_MRM runs
20170405_HCy_MRM_AKCMFCS_analysis01_lvl500_Repl1_2019-09-12_14-54-01.sky.zip2019-09-14 16:21:4124828234710Primary human keratinocyte conditioned media containing FCS_500 pg/mL cytokines spiked-in_High pH reversed-phase peptide fractionation_Reproducibility experiment_Day 2_Replicate 1_MRM runs
20170405_HCy_MRM_AKCMFCS_analysis01_lvl500_Repl2_2019-09-12_14-54-27.sky.zip2019-09-14 16:21:4224828234710Primary human keratinocyte conditioned media containing FCS_500 pg/mL cytokines spiked-in_High pH reversed-phase peptide fractionation_Reproducibility experiment_Day 2_Replicate 2_MRM runs
20170405_HCy_MRM_AKCMFCS_analysis01_lvl500_Repl3_2019-09-12_14-54-54.sky.zip2019-09-14 16:21:4224828234710Primary human keratinocyte conditioned media containing FCS_500 pg/mL cytokines spiked-in_High pH reversed-phase peptide fractionation_Reproducibility experiment_Day 2_Replicate 3_MRM runs
20170405_HCy_MRM_AKCMFCS_analysis01_lvl500_Repl4_2019-09-12_14-55-21.sky.zip2019-09-14 16:21:4224828234710Primary human keratinocyte conditioned media containing FCS_500 pg/mL cytokines spiked-in_High pH reversed-phase peptide fractionation_Reproducibility experiment_Day 2_Replicate 4_MRM runs
20170325_HCy_MRM_AKCMFCS_lvl500_Repl1-4_analysis01_2019-09-12_14-53-38.sky.zip2019-09-14 16:21:422482823516Primary human keratinocyte conditioned media containing FCS_500 pg/mL cytokines spiked-in_No fractionation_Reproducibility experiment_Day 1_Replicate 1-4_MRM runs
20170405_HCy_MRM_AKCMFCS_lvl500_Repl1-4_analysis02_2019-09-12_14-55-48.sky.zip2019-09-14 16:21:422482823516Primary human keratinocyte conditioned media containing FCS_500 pg/mL cytokines spiked-in_No fractionation_Reproducibility experiment_Day 2_Replicate 1-4_MRM runs
20170201_HCy_MRM_AKCMFCS_analysis01_lvl75_2019-09-12_14-38-49.sky.zip2019-09-14 16:21:4124828235410Primary human keratinocyte conditioned media containing FCS_75 pg/mL cytokines spiked-in_High pH reversed-phase peptide fractionation_MRM runs
20170201_HCy_MRM_AKCMFCS_analysis01_lvl0_2019-09-12_14-35-27.sky.zip2019-09-14 16:21:4024828235410Primary human keratinocyte conditioned media containing FCS_No cytokines spiked-in_High pH reversed-phase peptide fractionation_MRM runs
20170210_HCy_MRM_AKCM_analysis01_2019-09-12_14-49-54.sky.zip2019-09-14 16:21:412482823519Primary human keratinocyte conditioned media without FCS_0 pg/mL - 1000 pg/mL cytokines spiked-in_No fractionation_MRM runs
20170206_HCy_MRM_AKCM_analysis01_lvl1000_2019-09-12_14-48-10.sky.zip2019-09-14 16:21:4124828235010Primary human keratinocyte conditioned media without FCS_1000 pg/mL cytokines spiked-in_High pH reversed-phase peptide fractionation_MRM runs
20170206_HCy_MRM_AKCM_analysis01_lvl125_2019-09-12_14-46-44.sky.zip2019-09-14 16:21:4124828235010Primary human keratinocyte conditioned media without FCS_125 pg/mL cytokines spiked-in_High pH reversed-phase peptide fractionation_MRM runs
20170206_HCy_MRM_AKCM_analysis01_lvl250_2019-09-12_14-47-12.sky.zip2019-09-14 16:21:4124828235010Primary human keratinocyte conditioned media without FCS_250 pg/mL cytokines spiked-in_High pH reversed-phase peptide fractionation_MRM runs
20170206_HCy_MRM_AKCM_analysis01_lvl37-5_2019-09-12_14-45-50.sky.zip2019-09-14 16:21:4124828235010Primary human keratinocyte conditioned media without FCS_37.5 pg/mL cytokines spiked-in_High pH reversed-phase peptide fractionation_MRM runs
20170206_HCy_MRM_AKCM_analysis01_lvl500_2019-09-12_14-47-45.sky.zip2019-09-14 16:21:4124828235010Primary human keratinocyte conditioned media without FCS_500 pg/mL cytokines spiked-in_High pH reversed-phase peptide fractionation_MRM runs